Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

Published:2018 Issue: Volume:11 Page:39
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Celebi Sozener Zeynep,Gorgulu Begum,Mungan Dilsad,Sin Betul Ayse,Misirligil Zeynep,Aydin Omur,Bavbek Sevim

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40413-018-0217-0.pdf

Reference33 articles.

1. Treatment with eosinophilic granulomatosis with polyangiitis: a review;Raffray;Drugs,2018

2. Churg-Strauss syndrome;Greco;Autoimmun Rev,2015

3. EGPA Mepolizumab study team. Mepolizumab or placebo for eosinophilic granulomatosis with Polyangiitis;Wechsler;N Engl J Med,2017

4. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE;Humbert;Allergy,2005

5. The use of anti-IgE therapy beyond allergic asthma;Stokes;J Allergy Clin Immunol Pract,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of omalizumab treatment in chronic eosinophilic pneumonia: Real-life data;Tuberk Toraks;2024-03-26

2. Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons;Expert Review of Clinical Immunology;2024-03-06

3. Evidencia terapéutica del mepolizumab en la granulomatosis eosinofílica con poliangeítis: una revisión exploratoria;Revista Colombiana de Reumatología;2024-02

4. Biologics for severe asthma and beyond;Pharmacology & Therapeutics;2023-12

5. Renal involvement in eosinophilic granulomatosis with polyangiitis;Frontiers in Medicine;2023-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3